Indication
Urologic Malignancies
1 clinical trial
1 product
Product
BBI503Clinical trial
A Phase II Clinical Study of BBI503 in Adult Patients With Advanced Urologic MalignanciesStatus: Withdrawn, Estimated PCD: 2018-08-01
1 clinical trial
1 product